投稿咨詢
Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed.
Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports.
Coverage includes:
? Novel therapeutic strategies
? High-throughput screening
? Therapeutic targets
? Combinatorial chemistry, parallel synthesis and library design
? Drug delivery
? ADME/Tox
? Advances in key compound classes and therapeutic areas
? Genomics and proteomics
? Automation and technology
? Virtual chemistry
? Informatics
? Business strategy
? Clinical trials
and other aspects of drug discovery.
《Drug Discovery Today》是一本由ELSEVIER SCI LTD出版商出版的專業醫學期刊，該刊創刊于1996年，刊期Semimonthly，該刊已被國際權威數據庫SCIE、SCI收錄。在中科院最新升級版分區表中，該刊分區信息為大類學科：醫學 2區，小類學科：藥學 1區；在JCR（Journal Citation Reports）分區等級為Q1。該刊發文范圍涵蓋藥學等領域，旨在及時、準確、全面地報道國內外藥學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等，促進學術交流，鼓勵學術創新。2021年影響因子為8.369，平均審稿速度約6.0個月。
| 大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
| 醫學 | 2區 | PHARMACOLOGY & PHARMACY 藥學 | 2區 | 否 | 是 |
| JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
| Q1 | PHARMACOLOGY & PHARMACY | Q1 | 8.369 |
| 影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
| 8.369 | 157 | 15.42% | 0.38% | 未開放 | 約6.0個月 |
課題、SCI/EI/SSCI怎么寫？